Ashani Weeraratna
Department Chair, Bloomberg Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
About
Ashani Weeraratna is the Department Chair and Bloomberg Professor at Johns Hopkins University Bloomberg School of Public Health. Her research primarily focuses on the genetics and epigenetics of the ageing tumour microenvironment, exploring how these factors influence tumour progression and metastasis. Recent articles authored by Dr. Weeraratna examine the role of the ageing extracellular matrix in cancer dynamics, as well as broader implications for academia and the future of scholarly work. She is dedicated to advancing understanding in these critical areas within public health.
Articles (13)
Background Melanoma is the deadliest form of skin cancer, with increasing incidence rates among the older population. The immune system experiences age‐related changes that can impact tumor progression and treatment efficacy. Additionally, aging leads to systemic non‐immune changes, such as enhanced adiposity and iron accumulation in the bone marrow (BM). Aims This study aims to investigate how age‐related alterations in the BM, alongside the presence of melanoma, influence the immune response and susceptibility to ferroptosis in aged mice. Methods and Results Utilizing an aged mouse model with melanoma, we observed significant changes in iron and lipid levels within the BM, as well as alterations in immune cell populations. Specifically, our findings indicate that tumor burden expands the myeloid compartment and contracts the lymphoid compartment in the BM niche. Aging increases neutral lipids within the BM, but tumor burden in aged mice appears to reverse this effect. We noted elevated intracellular neutral lipid levels in monocytes due to the tumor burden. Bone marrow–derived macrophages (BMDMs) from aged mice exhibited altered fatty acid synthase and fatty acid uptake protein expression. While aging leads to increased iron accumulation and lipid peroxidation in the BM, the presence of melanoma counteracts these changes. Disruptions in iron and lipid homeostasis heightened the risk of ferroptosis. Notably, imidazole ketone erastin and aging influenced intracellular ferrous iron levels and immune cell populations. Conclusion Overall, melanoma induces an age‐specific metabolic response in the BM, which may sensitize immune cells to ferroptosis inducers.
Year:
2026
Year:
2025
Pancreatic ductal adenocarcinoma (PDAC) is a rapidly progressing cancer that responds poorly to immunotherapies. Intratumoral tertiary lymphoid structures (TLS) have been associated with rare long-term PDAC survivors, but the role of TLS in PDAC and their spatial relationships within the context of the broader tumor microenvironment remain unknown. In this study, we report the generation of a spatial multiomic atlas of PDAC tumors and tumor-adjacent lymph nodes from patients treated with combination neoadjuvant immunotherapies. Using machine learning–enabled hematoxylin and eosin image classification models, imaging mass cytometry, and unsupervised gene expression matrix factorization methods for spatial transcriptomics, we characterized cellular states within and adjacent to TLS spanning distinct spatial niches and pathologic responses. Unsupervised learning identified TLS-specific spatial gene expression signatures that are significantly associated with improved survival in patients with PDAC. We identified spatial features of pathologic immune responses, including intratumoral TLS–associated B-cell maturation colocalizing with IgG dissemination and extracellular matrix remodeling. Our findings offer insights into the cellular and molecular landscape of TLS in PDACs during immunotherapy treatment.
Year:
2025
Longitudinal imaging of 3D cell cultures like tumor organoids and spheroids offers crucial insights into cancer progression and treatment. However, spatial displacement during time-course imaging, caused by matrix detachment or experimental artifacts, can confound analyses. Existing computational methods struggle to address this issue. We present a new algorithm to evaluate data integrity and rectify mislabeling in longitudinal imaging of 3D cell culture. Our algorithm integrates permutation-based optimization with Procrustes analysis. By using X and Y coordinates of images, it accurately reorders, matches, and aligns object positions across time points, correcting for rotation, translation, and small movements. Validation with simulated data confirmed its accuracy and robustness. Applied to longitudinal imaging of tumor spheroids, our algorithm revealed frequent displacement amongst the spheroids between time points and corrected many mislabeled images. This computationally efficient and adaptable method needs no experimental adjustments and presents a readily accessible solution for data quality control. Motivation Three-dimensional (3D) in vitro models, such as tumor organoids and spheroids embedded in an extracellular matrix, are increasingly vital for studying normal and disease biology, including drug responses. 1–3 A key advantage of these models is that imaging platforms can perform continuous longitudinal imaging to track phenotypic changes. However, common issues in 3D techniques, such as matrix shifts during experimental setup or image capture, can introduce technical artifacts that affect downstream analyses. Currently, no automated analytical approaches exist for assessing or correcting technical artifacts. Here, we introduce a robust, automated algorithm for assessing the quality of time-course image data and, in some cases, correcting object mislabeling to enable accurate tracking of individual spheroids over time. This approach relies only on image metadata, requiring no experimental modifications. It offers a readily implementable solution for improving data integrity and reproducibility and enhancing the reliability of longitudinal 3D cell culture studies.
Year:
2025
Aged patients with melanoma (>65 years old) have more aggressive disease relative to young patients ( 5-fold levels of IGF-binding protein 2 (IGFBP2) in the aged fibroblast secretome. IGFBP2 functionally triggers upregulation of the PI3K-dependent fatty acid biosynthesis program in melanoma cells. Melanoma cells co-cultured with aged dermal fibroblasts have higher levels of lipids relative to those co-cultured with young dermal fibroblasts, which can be lowered by silencing IGFBP2 expression in fibroblasts prior to treating with conditioned media. Conversely, ectopically treating melanoma cells with recombinant IGFBP2 in the presence of conditioned media from young fibroblasts or overexpressing IGFBP2 in melanoma cells promoted lipid synthesis and accumulation in melanoma cells. Treatment of young mice with rIGFBP2 increases tumor growth. Neutralizing IGFBP2 in vitro reduces migration and invasion in melanoma cells, and in vivo studies demonstrate that neutralizing IGFBP2 in syngeneic aged mice reduces tumor growth and metastasis. Our results suggest that aged dermal fibroblasts increase melanoma cell aggressiveness through increased secretion of IGFBP2, stressing the importance of considering age when designing studies and treatment. Significance: The aged microenvironment drives metastasis in melanoma cells. This study reports that IGFBP2 secretion by aged fibroblasts induces lipid accumulation in melanoma cells, driving an increase in tumor invasiveness. Neutralizing IGFBP2 decreases melanoma tumor growth and metastasis.
Year:
2025
Pancreatic adenocarcinoma (PDAC) is a rapidly progressing cancer that responds poorly to immunotherapies. Intratumoral tertiary lymphoid structures (TLS) have been associated with rare long-term PDAC survivors, but the role of TLS in PDAC and their spatial relationships within the context of the broader tumor microenvironment remain unknown. We generated a spatial multi-omics atlas encompassing 26 PDAC tumors from patients treated with combination immunotherapies. Using machine learning-enabled H&E image classification models and unsupervised gene expression matrix factorization methods for spatial transcriptomics, we characterized cellular states within TLS niches spanning across distinct morphologies and immunotherapies. Unsupervised learning generated a TLS-specific spatial gene expression signature that significantly associates with improved survival in PDAC patients. These analyses demonstrate TLS-associated intratumoral B cell maturation in pathological responders, confirmed with spatial proteomics and BCR profiling. Our study also identifies spatial features of pathologic immune responses, revealing TLS maturation colocalizing with IgG/IgA distribution and extracellular matrix remodeling. GRAPHICAL ABSTRACT HIGHLIGHTS Integrated multi-modal spatial profiling of human PDAC tumors from neoadjuvant immunotherapy clinical trials reveal diverse spatial niches enriched in TLS. TLS maturity is influenced by tumor location and the cellular neighborhoods in which TLS immune cells are recruited. Unsupervised machine learning of genome-wide signatures on spatial transcriptomics data characterizes the TLS-enriched TME and associates TLS transcriptomes with survival outcomes in PDAC. Interactions of spatially variable gene expression patterns showed TLS maturation is coupled with immunoglobulin distribution and ECM remodeling in pathologic responders. Intratumoral plasma cell and immunoglobin gene expression spatial dynamics demonstrate trafficking of TLS-driven humoral immunity in the PDAC TME. Significance We report a spatial multi-omics atlas of PDAC tumors from a series of immunotherapy neoadjuvant clinical trials. Intratumorally, pathologic responders exhibit mature TLS that propagate plasma cells into malignant niches. Our findings offer insights on the role of TLS-associated humoral immunity and stromal remodeling during immunotherapy treatment.
Year:
2024
Aged patients with melanoma (>65 years old) have more aggressive disease relative to young patients ( 5-fold levels of IGF-binding protein 2 (IGFBP2) in the aged fibroblast secretome. IGFBP2 functionally triggers upregulation of the PI3K-dependent fatty acid biosynthesis program in melanoma cells. Melanoma cells co-cultured with aged dermal fibroblasts have higher levels of lipids relative to those co-cultured with young dermal fibroblasts, which can be lowered by silencing IGFBP2 expression in fibroblasts prior to treating with conditioned media. Conversely, ectopically treating melanoma cells with recombinant IGFBP2 in the presence of conditioned media from young fibroblasts or overexpressing IGFBP2 in melanoma cells promoted lipid synthesis and accumulation in melanoma cells. Treatment of young mice with rIGFBP2 increases tumor growth. Neutralizing IGFBP2 in vitro reduces migration and invasion in melanoma cells, and in vivo studies demonstrate that neutralizing IGFBP2 in syngeneic aged mice reduces tumor growth and metastasis. Our results suggest that aged dermal fibroblasts increase melanoma cell aggressiveness through increased secretion of IGFBP2, stressing the importance of considering age when designing studies and treatment. Significance: The aged microenvironment drives metastasis in melanoma cells. This study reports that IGFBP2 secretion by aged fibroblasts induces lipid accumulation in melanoma cells, driving an increase in tumor invasiveness. Neutralizing IGFBP2 decreases melanoma tumor growth and metastasis.
Year:
2024
Pancreatic cancer is more prevalent in older individuals and often carries a poorer prognosis for them. The relationship between the microenvironment and pancreatic cancer is multifactorial, and age-related changes in nonmalignant cells in the tumor microenvironment may play a key role in promoting cancer aggressiveness. Because fibroblasts have profound impacts on pancreatic cancer progression, we investigated whether age-related changes in pancreatic fibroblasts influence cancer growth and metastasis. Proteomics analysis revealed that aged fibroblasts secrete different factors than young fibroblasts, including increased growth/differentiation factor 15 (GDF-15). Treating young mice with GDF-15 enhanced tumor growth, whereas aged GDF-15 knockout mice showed reduced tumor growth. GDF-15 activated AKT, rendering tumors sensitive to AKT inhibition in an aged but not young microenvironment. These data provide evidence for how aging alters pancreatic fibroblasts and promotes tumor progression, providing potential therapeutic targets and avenues for studying pancreatic cancer while accounting for the effects of aging. Significance: Aged pancreatic fibroblasts secrete GDF-15 and activate AKT signaling to promote pancreatic cancer growth, highlighting the critical role of aging-mediated changes in the pancreatic cancer microenvironment in driving tumor progression. See related commentary by Isaacson et al., p. 1185
Year:
2024
Pancreatic cancer is more prevalent in older individuals and often carries a poorer prognosis for them. The relationship between the microenvironment and pancreatic cancer is multifactorial, and age-related changes in nonmalignant cells in the tumor microenvironment may play a key role in promoting cancer aggressiveness. Because fibroblasts have profound impacts on pancreatic cancer progression, we investigated whether age-related changes in pancreatic fibroblasts influence cancer growth and metastasis. Proteomics analysis revealed that aged fibroblasts secrete different factors than young fibroblasts, including increased growth/differentiation factor 15 (GDF-15). Treating young mice with GDF-15 enhanced tumor growth, whereas aged GDF-15 knockout mice showed reduced tumor growth. GDF-15 activated AKT, rendering tumors sensitive to AKT inhibition in an aged but not young microenvironment. These data provide evidence for how aging alters pancreatic fibroblasts and promotes tumor progression, providing potential therapeutic targets and avenues for studying pancreatic cancer while accounting for the effects of aging. Significance: Aged pancreatic fibroblasts secrete GDF-15 and activate AKT signaling to promote pancreatic cancer growth, highlighting the critical role of aging-mediated changes in the pancreatic cancer microenvironment in driving tumor progression. See related commentary by Isaacson et al., p. 1185
Year:
2024
Year:
2023
Year:
2023
Year:
2020
Year:
2020
Collaborators (26)
Genevieve Stein-O'Brien
Assistant Professor
Johns Hopkins University School of Medicine
Steven Hughes
Professor and Chief, General Surgery
University of Florida
Alexander Girgis
Johns Hopkins University
Gretchen Alicea-Gutierrez
Assistant Professor
University of Maryland Baltimore County
Song Han
Assistant Professsor
University of Florida
Luciane Tsukamoto Kagohara
Assistant Professor
Johns Hopkins University
Jacquelyn W. Zimmerman
Johns Hopkins University School of Medicine
Daniel Zabransky
Johns Hopkins University
Lucie Dequiedt
Johns Hopkins University
Daniel Delitto
Assistant Professor
Stanford University
Mark Yarchoan
Johns Hopkins University
Vito Rebecca
Assistant Professor
Johns Hopkins University
Mitchell Fane
Assistant Professor
Fox Chase Cancer Center
Dimitrios Sidiropoulos
Assistant Professor
Johns Hopkins University
Gabriel Ghiaur
Associate Professor
Johns Hopkins University School of Medicine
Young Hwan Chang
Associate Professor
Oregon Health & Science University
David W Speicher
Professor
The Wistar Institute
Daniel Bergman
Assistant Professor
Johns Hopkins University
Andrew Kossenkov
Assistant Professor
The Wistar Institute
Won Jin Ho
Johns Hopkins University School of Medicine
Denis Wirtz
TH Professor
Johns Hopkins University
Elizabeth M. Jaffee
Johns Hopkins University School of Medicine
Hsin-Yao Tang
Co-Scientific Director
The Wistar Institute
Yash Chhabra
Assistant Professor
Fox Chase Cancer Center
Elana Fertig
Assistant Professor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Todd Armstrong
Johns Hopkins University
Make your next move.
Prepare your application
Review drafts before you send them.